Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Lixte Biotechnology Holdings, Inc. (LIXT.OB) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Lixte Biotechnology Holdings, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1335105.
Total stock buying since 2016: $2,996,794.
Total stock sales since 2016: $0.
Total stock option exercises since 2016: $101,000.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 20,000 | $52,115 | 0 | $0 | 0 | $0 |
| 2022 | 134,376 | $118,531 | 0 | $0 | 0 | $0 |
| 2021 | 0 | $0 | 0 | $0 | 125,001 | $101,000 |
| 2020 | 315,839 | $1,500,233 | 0 | $0 | 0 | $0 |
| 2018 | 2,500,000 | $1,250,000 | 0 | $0 | 0 | $0 |
| 2017 | 1,005,556 | $59,327 | 0 | $0 | 0 | $0 |
| 2016 | 56,000 | $16,588 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-10 | 20,000 | $52,115 | 0 | $0 | 0 | $0 |
| 2022-12 | 36,112 | $65,073 | 0 | $0 | 0 | $0 |
| 2022-11 | 98,264 | $53,458 | 0 | $0 | 0 | $0 |
| 2021-04 | 0 | $0 | 0 | $0 | 125,001 | $101,000 |
| 2020-11 | 315,839 | $1,500,233 | 0 | $0 | 0 | $0 |
| 2018-12 | 2,500,000 | $1,250,000 | 0 | $0 | 0 | $0 |
| 2017-01 | 1,005,556 | $59,327 | 0 | $0 | 0 | $0 |
| 2016-02 | 56,000 | $16,588 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-10-03 | Bernards Rene | Buy | 5,527 | 2.51 | 13,872 |
| 2023-10-03 | Van Der Baan Bastiaan Jeroen (President and CEO) | Buy | 10,000 | 2.80 | 28,000 |
| 2023-10-02 | Bernards Rene | Buy | 4,473 | 2.29 | 10,243 |
| 2022-12-30 | Van Der Baan Bastiaan Jeroen | Buy | 10,000 | 4.90 | 49,000 |
| 2022-12-12 | Bernards Rene | Buy | 10,000 | .61 | 6,100 |
| 2022-12-09 | Forman Eric (Vice President and COO) | Buy | 16,112 | .62 | 9,973 |
| 2022-11-22 | Forman Eric (Vice President and COO) | Buy | 7,452 | .56 | 4,173 |
| 2022-11-21 | Brown Regina | Buy | 5,000 | .57 | 2,875 |
| 2022-11-21 | Forman Eric (Vice President and COO) | Buy | 4,371 | .56 | 2,445 |
| 2022-11-18 | Forman Eric (Vice President and COO) | Buy | 16,207 | .56 | 9,108 |
| 2022-11-17 | Forman Eric (Vice President and COO) | Buy | 4,852 | .54 | 2,620 |
| 2022-11-14 | Bernards Rene | Buy | 52,500 | .53 | 27,825 |
| 2021-04-22 | Forman Stephen J. | Option Ex | 33,334 | .96 | 32,000 |
| 2021-04-22 | Forman Eric (Secretary) | Option Ex | 16,667 | .90 | 15,000 |
| 2021-04-22 | Palmedo Philip F | Option Ex | 75,000 | .72 | 54,000 |
| 2020-11-30 | Ho Hung Tak | Buy | 42,105 | 4.75 | 199,998 |
| 2020-11-30 | Yen Yun | Buy | 52,632 | 4.75 | 250,002 |
| 2020-11-30 | Forman Stephen J. | Buy | 21,053 | 4.75 | 100,001 |
| 2020-11-30 | Schwartzberg Gil | Buy | 105,264 | 4.75 | 500,004 |
| 2020-11-30 | Palmedo Philip F | Buy | 21,053 | 4.75 | 100,001 |
| 2020-11-30 | Kovach John S (President and CEO) | Buy | 21,100 | 4.75 | 100,225 |
| 2020-11-30 | Greenberg Family Trust | Buy | 52,632 | 4.75 | 250,002 |
| 2018-12-07 | Forman Stephen J. (Director) | Buy | 100,000 | .50 | 50,000 |
| 2018-12-07 | Riggs Jane Merrill (10% Owner) | Buy | 1,260,000 | .50 | 630,000 |
| 2018-12-07 | Schwartzberg Gil (10% Owner) | Buy | 1,040,000 | .50 | 520,000 |
| 2018-12-07 | Palmedo Philip F (Director) | Buy | 100,000 | .50 | 50,000 |
| 2017-01-11 | Schwartzberg Gil | Buy | 1,005,556 | .06 | 59,327 |
| 2016-02-19 | Forman Eric | Buy | 10,000 | .30 | 3,000 |
| 2016-02-17 | Forman Eric | Buy | 43,500 | .30 | 12,963 |
| 2016-02-04 | Forman Eric | Buy | 2,500 | .25 | 625 |
Insider trading activities including stock purchases, stock sales, and option exercises of LIXT.OB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Lixte Biotechnology Holdings, Inc. (symbol LIXT.OB, CIK number 1335105) see the Securities and Exchange Commission (SEC) website.